NEOVACS (EPA:ALNEV) | WebDisclosure

Basculer en Français

9866	Companies
198282	Keywords
129317	Articles
105443	Press releases

Home
Companies
NEOVACS

PRESS RELEASE

published on 05/16/2025 at 18:30, 8 months 29 days ago

Information relative au nombre total de droits de vote et d'actions composant le capital social
Néovacs communique le nombre d'actions et de droits de vote composant son capital social conformément aux régulations. La société développe des thérapies pour des maladies inflammatoires et auto-immunes

Droits De Vote Capital Social Biopharmaceutique Néovacs Thérapies
BRIEF

published on 05/06/2025 at 20:05, 9 months 8 days ago

Capital reduction at Neovacs

Capital Reduction Investor Caution Dilutive Financing Nominal Value Stock Market Pressure
BRIEF

published on 05/06/2025 at 20:05, 9 months 8 days ago

Réduction du capital chez Néovacs

Valeur Nominale Réduction Capital Financements Dilutifs Pression Boursière Prudence Investisseur
PRESS RELEASE

published on 05/06/2025 at 20:00, 9 months 8 days ago

Ajustement de la valeur nominale
Réduction de capital pour Néovacs, société biopharmaceutique, suite à résolution votée en AG. Focus sur thérapies pour maladies inflammatoires et auto-immunes

Biopharmaceutique Réduction De Capital Maladies Inflammatoires Néovacs Thérapies
BRIEF

published on 05/06/2025 at 08:05, 9 months 9 days ago

Neovacs: 2024 Annual Results and Outlook

Financial Results Funding MRNA Vaccine Pharnext Néovacs
BRIEF

published on 05/06/2025 at 08:05, 9 months 9 days ago

Néovacs : Résultats annuels 2024 et perspectives

Résultats Financiers Financement Pharnext Néovacs Vaccin ARNm
PRESS RELEASE

published on 05/06/2025 at 08:00, 9 months 9 days ago

Résultats annuels 2024
Néovacs annonce des avancées dans le développement de vaccins ARNm contre les allergies, avec une valorisation par un cabinet indépendant. La société présente ses résultats annuels 2024 et son point sur le financement ainsi que le récentrage du portefeuille de participations et de l'investissement dans Pharnext

Financement Résultats Annuels Néovacs Allergies Vaccin ARNm
BRIEF

published on 05/05/2025 at 12:05, 9 months 10 days ago

Néovacs réalise une levée de fonds de 1,2 million d'euros

Investissement Biotechnologie Levée De Fonds Dilution OCEANE-BSA
BRIEF

published on 05/05/2025 at 12:05, 9 months 10 days ago

Neovacs raises 1.2 million euros in fundraising

Biotechnology Fundraising Investment Dilution OCEANE-BSA
PRESS RELEASE

published on 05/05/2025 at 12:00, 9 months 10 days ago

Levée de fonds de 1,2 MEUR
Néovacs annonce une levée de fonds de 1,2 M€ pour financer le programme de recherche Kinoïde® sur les allergies et renforcer les investissements en BioTech et MedTech

Biotech Levée De Fonds Néovacs Kinoïde® Allergies

Accesswire

Published on 02/14/2026 at 01:00, 1 day 12 hours ago

Orogen Royalties Announces Annual Equity Compensation Grant
Published on 02/13/2026 at 22:30, 1 day 15 hours ago

Norse Gold Corp. Announces New Director
Published on 02/13/2026 at 22:15, 1 day 15 hours ago

Storm Completes Sale of Miminiska Project for $5.8M and Outlines Plans for 2026
Published on 02/13/2026 at 17:45, 1 day 19 hours ago

Eldorado Gold Closes $2.4 Million Strategic Investment in Gemdale Gold
Published on 02/13/2026 at 14:35, 1 day 23 hours ago

Datametrex Received $500,000 Purchase Order For Data Centre Solutions

View all ACCESSWIRE

EQS Group

Published on 02/15/2026 at 11:43, 1 hour 54 minutes ago

EQS-Adhoc: The Management Board of Hapag-Lloyd Aktiengesellschaft confirms negotiations regarding an acquisition of Zim Integrated Shipping Services Ltd.
Published on 02/15/2026 at 11:05, 2 hours 32 minutes ago

WePlay Debuts in German Market with "The Little Prince" Special Valentine's Day Collaboration
Published on 02/15/2026 at 09:35, 4 hours 2 minutes ago

Canary Islands at the Berlinale European Film Market with more than 40 professionals from the islands
Published on 02/14/2026 at 16:30, 21 hours 7 minutes ago

Milano Cortina 2026 Licensed Candies Released Globally
Published on 02/14/2026 at 06:05, 1 day 7 hours ago

The 139th Canton Fair Promotion Conferences to Be Held in Germany and Morocco, Highlighting Targeted Industry Opportunities

Les Echos

Published on 02/14/2026 at 07:00, 1 day 6 hours ago

Groupe DLSI - Chiffre d'affaires 2025
Published on 02/13/2026 at 18:05, 1 day 19 hours ago

AXA : Information relative au nombre total de droits de vote et d'actions composant le capital social au 31/01/2026
Published on 02/13/2026 at 18:05, 1 day 19 hours ago

AXA: Information relating to the number of voting rights and shares making up the share capital on 31/01/2026
Published on 02/13/2026 at 17:50, 1 day 19 hours ago

Number of shares and voting rights - January 2026 (In French only)
Published on 02/13/2026 at 17:50, 1 day 19 hours ago

Nombre total d'actions et droits de vote - janvier 2026

View all LES ECHOS COMFI WIRE